PL2908836T3 - Formulacja farmaceutyczna zawierająca kurkuminę - Google Patents
Formulacja farmaceutyczna zawierająca kurkuminęInfo
- Publication number
- PL2908836T3 PL2908836T3 PL13740296T PL13740296T PL2908836T3 PL 2908836 T3 PL2908836 T3 PL 2908836T3 PL 13740296 T PL13740296 T PL 13740296T PL 13740296 T PL13740296 T PL 13740296T PL 2908836 T3 PL2908836 T3 PL 2908836T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical formulation
- formulation containing
- containing curcumin
- curcumin
- pharmaceutical
- Prior art date
Links
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 title 2
- 229940109262 curcumin Drugs 0.000 title 1
- 235000012754 curcumin Nutrition 0.000 title 1
- 239000004148 curcumin Substances 0.000 title 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10F—INORGANIC SEMICONDUCTOR DEVICES SENSITIVE TO INFRARED RADIATION, LIGHT, ELECTROMAGNETIC RADIATION OF SHORTER WAVELENGTH OR CORPUSCULAR RADIATION
- H10F19/00—Integrated devices, or assemblies of multiple devices, comprising at least one photovoltaic cell covered by group H10F10/00, e.g. photovoltaic modules
- H10F19/90—Structures for connecting between photovoltaic cells, e.g. interconnections or insulating spacers
- H10F19/902—Structures for connecting between photovoltaic cells, e.g. interconnections or insulating spacers for series or parallel connection of photovoltaic cells
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10F—INORGANIC SEMICONDUCTOR DEVICES SENSITIVE TO INFRARED RADIATION, LIGHT, ELECTROMAGNETIC RADIATION OF SHORTER WAVELENGTH OR CORPUSCULAR RADIATION
- H10F19/00—Integrated devices, or assemblies of multiple devices, comprising at least one photovoltaic cell covered by group H10F10/00, e.g. photovoltaic modules
- H10F19/90—Structures for connecting between photovoltaic cells, e.g. interconnections or insulating spacers
- H10F19/902—Structures for connecting between photovoltaic cells, e.g. interconnections or insulating spacers for series or parallel connection of photovoltaic cells
- H10F19/904—Structures for connecting between photovoltaic cells, e.g. interconnections or insulating spacers for series or parallel connection of photovoltaic cells characterised by the shapes of the structures
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10F—INORGANIC SEMICONDUCTOR DEVICES SENSITIVE TO INFRARED RADIATION, LIGHT, ELECTROMAGNETIC RADIATION OF SHORTER WAVELENGTH OR CORPUSCULAR RADIATION
- H10F77/00—Constructional details of devices covered by this subclass
- H10F77/40—Optical elements or arrangements
- H10F77/42—Optical elements or arrangements directly associated or integrated with photovoltaic cells, e.g. light-reflecting means or light-concentrating means
- H10F77/488—Reflecting light-concentrating means, e.g. parabolic mirrors or concentrators using total internal reflection
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E10/00—Energy generation through renewable energy sources
- Y02E10/50—Photovoltaic [PV] energy
- Y02E10/52—PV systems with concentrators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102012219219.0A DE102012219219A1 (de) | 2012-10-22 | 2012-10-22 | Pharmazeutische Formulierung enthaltend Curcumin |
| EP13740296.2A EP2908836B1 (de) | 2012-10-22 | 2013-07-24 | Pharmazeutische formulierung enthaltend curcumin |
| PCT/EP2013/065661 WO2014063844A1 (de) | 2012-10-22 | 2013-07-24 | Pharmazeutische formulierung enthaltend curcumin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2908836T3 true PL2908836T3 (pl) | 2020-06-15 |
Family
ID=48874303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13740296T PL2908836T3 (pl) | 2012-10-22 | 2013-07-24 | Formulacja farmaceutyczna zawierająca kurkuminę |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US11382871B2 (pl) |
| EP (1) | EP2908836B1 (pl) |
| CY (1) | CY1122694T1 (pl) |
| DE (2) | DE202012013584U1 (pl) |
| DK (1) | DK2908836T3 (pl) |
| ES (1) | ES2759621T3 (pl) |
| HR (1) | HRP20192208T1 (pl) |
| HU (1) | HUE046492T2 (pl) |
| LT (1) | LT2908836T (pl) |
| PL (1) | PL2908836T3 (pl) |
| PT (1) | PT2908836T (pl) |
| RS (1) | RS59631B1 (pl) |
| SI (1) | SI2908836T1 (pl) |
| SM (1) | SMT201900688T1 (pl) |
| WO (1) | WO2014063844A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10660967B2 (en) | 2016-10-21 | 2020-05-26 | Augusta University Research Institute, Inc. | Curcumin conjugates and methods of use thereof |
| EP3275430B1 (de) * | 2017-04-07 | 2023-06-21 | Rohan Charles Fernando | Curcuminlösung zur intravenösen infusion |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2669918C (en) * | 2006-11-15 | 2020-03-10 | Arthritis Relief Plus Ltd | Topical formulation comprising comfrey and tannic acid, and uses thereof |
| WO2009073050A2 (en) * | 2007-07-27 | 2009-06-11 | Research Foundation Of City University Of New York | Use of curcumin to block brain tumor formation in vivo |
| CN101138550B (zh) | 2007-09-18 | 2012-06-27 | 沈阳药科大学 | 多种表面活性剂联合使用制备的混合胶束药物制剂及其制备方法 |
| KR20090047637A (ko) * | 2007-11-08 | 2009-05-13 | 재단법인서울대학교산학협력재단 | 커큐민 또는 이의 약학적으로 허용가능한 염을유효성분으로 함유하는 통증 예방 및 치료용 조성물 |
| WO2010010431A1 (en) | 2008-07-24 | 2010-01-28 | National Institute Of Pharmaceutical Education And Research | Self-nano-emulsifying curcuminoids composition with enhanced bioavailability |
| CN101548946B (zh) * | 2009-02-17 | 2012-04-25 | 海口市制药厂有限公司 | 姜黄素纳米脂质注射液、其制备方法及用途 |
| IT1395086B1 (it) | 2009-03-11 | 2012-09-05 | Velleja Res Srl | Composizioni comprendenti curcumina in forma complessata con fosfolipidi e piperina ad azione chemio-sensibilizzante |
| WO2011101859A1 (en) * | 2010-02-22 | 2011-08-25 | Institute Of Life Sciences | A novel water soluble curcumin loaded nanoparticulate system for cancer therapy |
| EP2616053B1 (en) * | 2010-09-15 | 2016-11-02 | Cadila Pharmaceuticals Ltd. | Pharmaceutical compositions of curcumin |
| CN102225048A (zh) * | 2011-04-27 | 2011-10-26 | 中国人民解放军第二军医大学 | 一种姜黄素类化合物注射溶液及其静脉注射剂 |
| CN102670574A (zh) * | 2012-05-15 | 2012-09-19 | 中国人民解放军总医院 | 姜黄素在制备治疗肠缺血再灌注损伤药物中的应用 |
-
2012
- 2012-10-22 DE DE202012013584.8U patent/DE202012013584U1/de not_active Expired - Lifetime
- 2012-10-22 DE DE102012219219.0A patent/DE102012219219A1/de not_active Withdrawn
-
2013
- 2013-07-24 ES ES13740296T patent/ES2759621T3/es active Active
- 2013-07-24 US US14/437,722 patent/US11382871B2/en active Active
- 2013-07-24 HR HRP20192208TT patent/HRP20192208T1/hr unknown
- 2013-07-24 SI SI201331631T patent/SI2908836T1/sl unknown
- 2013-07-24 DK DK13740296.2T patent/DK2908836T3/da active
- 2013-07-24 RS RS20191567A patent/RS59631B1/sr unknown
- 2013-07-24 WO PCT/EP2013/065661 patent/WO2014063844A1/de not_active Ceased
- 2013-07-24 PL PL13740296T patent/PL2908836T3/pl unknown
- 2013-07-24 EP EP13740296.2A patent/EP2908836B1/de active Active
- 2013-07-24 HU HUE13740296A patent/HUE046492T2/hu unknown
- 2013-07-24 SM SM20190688T patent/SMT201900688T1/it unknown
- 2013-07-24 LT LTEP13740296.2T patent/LT2908836T/lt unknown
- 2013-07-24 PT PT137402962T patent/PT2908836T/pt unknown
-
2019
- 2019-12-03 CY CY20191101266T patent/CY1122694T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SMT201900688T1 (it) | 2020-01-14 |
| LT2908836T (lt) | 2020-01-27 |
| PT2908836T (pt) | 2019-12-16 |
| EP2908836A1 (de) | 2015-08-26 |
| WO2014063844A1 (de) | 2014-05-01 |
| EP2908836B1 (de) | 2019-09-11 |
| DK2908836T3 (da) | 2019-12-16 |
| CY1122694T1 (el) | 2021-03-12 |
| RS59631B1 (sr) | 2020-01-31 |
| US20150342904A1 (en) | 2015-12-03 |
| DE202012013584U1 (de) | 2018-01-15 |
| ES2759621T3 (es) | 2020-05-11 |
| HRP20192208T1 (hr) | 2020-02-21 |
| SI2908836T1 (sl) | 2020-02-28 |
| DE102012219219A1 (de) | 2014-05-28 |
| HUE046492T2 (hu) | 2020-03-30 |
| US11382871B2 (en) | 2022-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3181128T3 (da) | Farmaceutisk nilotinib-sammensætning | |
| BR112015003125A2 (pt) | ingrediente hidrante cosmético ou7 farmacêutico | |
| PT2854768T (pt) | Composições farmacêuticas de pemetrexed | |
| DK2897594T3 (da) | Farmaceutisk sammensætning | |
| CO6940426A2 (es) | Formulaciones farmacéuticas | |
| CL2014003283A1 (es) | Formulación farmacéutica. | |
| DK2868318T4 (da) | Injicerbar formulering | |
| DK2815752T3 (da) | Oral farmaceutisk sammensætning | |
| HUE049942T2 (hu) | Inozitolt tartalmazó gyógyszerészeti formuláció | |
| EP2815753A4 (en) | ORAL PHARMACEUTICAL COMPOSITION | |
| EP2883547A4 (en) | MEDICINE | |
| DK3473255T3 (da) | Farmaceutisk formulering omfattende ciclesonid | |
| ZA201405925B (en) | Pharmaceutical formulation having improved stability | |
| BR112015002646A2 (pt) | composto e composição farmacêutica | |
| SMT201600419B (it) | Composizione farmaceutica contenente fosfolipidi | |
| PL2892528T3 (pl) | Kompozycje farmaceutyczne zawierające flurbiprofen | |
| PL2908836T3 (pl) | Formulacja farmaceutyczna zawierająca kurkuminę | |
| EP2897590A4 (en) | PHARMACEUTICAL COMPOSITION | |
| BR112014021433A2 (pt) | formulações farmacêuticas | |
| PL2922571T3 (pl) | Postać farmaceutyczna zawierająca metaloporfiryny zawierające karboran | |
| EP2851078A4 (en) | PHARMACEUTICAL COMPOSITION | |
| EP2884963A4 (en) | STABLE PHARMACEUTICAL FORMULATION OF CABAZITAXEL | |
| ECSP12011630A (es) | Formulación farmacéutica | |
| TH148806B (th) | สูตรผสมทางเภสัชกรรมที่มีความคงตัวดีขึ้น | |
| TH1301004215B (th) | องค์ประกอบเชิงเภสัชกรรมซึ่งประกอบรวมด้วยอนุพันธ์ไพริโอน |